Wave Life Sciences shareholders approve 8M share increase to equity plan

Wave Life Sciences Ltd.

Shareholders approved 8M share increase to 2021 Equity Incentive Plan (105.9M for, 24.6M against).
All nine director nominees re-elected, including Paul Bolno and Christian Henry.
KPMG ratified as independent auditor for FY2025 with 144.5M votes for.
Advisory executive compensation vote passed with 129.6M for; shareholders favored annual frequency (130.2M for one-year).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.